Regorafenib inhibited gastric cancer cells growth and invasion via CXCR4 activated Wnt pathway.
Xiao-Lin LinQi XuLei TangLi SunTing HanLi-Wei WangXiu-Ying XiaoPublished in: PloS one (2017)
Our findings demonstrated that regorafenib effectively inhibited cell proliferation and invasion of gastric cancer cells via decreasing the expression of CXCR4 and further reducing the transcriptional activity of Wnt/β-Catenin pathway.